AI Article Synopsis
- The treatment of metastatic bone disease is increasingly important due to rising survival rates from primary cancers, leading to more diagnoses.
- While curing metastatic disease is often not possible, enhancing patients' quality of life is a key focus for healthcare providers.
- A multidisciplinary team approach, combining advances in science with collaborative care, is essential for optimizing treatment options for these complex patients.
Article Abstract
The treatment of metastatic disease remains challenging. The number of patients who will be diagnosed with metastatic bone disease will continue to increase as survival from the primary cancer diagnosis continues to improve. Although it often is impossible to cure these patients, the task of maximizing their quality of life must be met with valiant efforts. Although a large number of medical and technological advances have occurred, perhaps the recognition of the importance of a well-qualified multidisciplinary team approach to treatment of these complex patients has done more to improve the field than any other single achievement. As basic science continues to further unravel potential treatment options, we must not forget this integrated approach and we must embrace "the bench" at the bedside.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/01477447-20060701-01 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!